EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Value of pancreatic duct stent placement combined with octreotide for reducing the postoperative pancreatic fistula rate in patients with diabetes undergoing pancreaticoduodenectomy

Kaisaier Abudouhadier, Jia-Qi Xu, Hai Lin

World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)

DOI: 10.4240/wjgs.123131 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Pancreaticoduodenectomy (PD) carries high postoperative complication risks, and postoperative pancreatic fistula is most common. Diabetes further elevates this risk due to impaired healing and immunity. Pancreatic duct stents and octreotide are widely used for prevention, but relevant studies targeting diabetic patients remain insufficient. This study explored the combined application of the two interventions. AIM To investigate the effect of combined therapy on postoperative pancreatic fistula in diabetic PD patients. METHODS Data from 156 patients with diabetes who underwent PD at our hospital from January 2022 to September 2025 were collected. The patients were divided into a combination group and a control group. In the control group, pancreatic duct stent was placed intraoperatively and routine postoperative care was given. In the combination group, intravenous octreotide infusion was added postoperatively. The incidence of postoperative pancreatic fistula, duration of drain retention, glycemic variability, and length of hospital stay were compared between the two groups. RESULTS A total of 60 patients were included in each group, and baseline characteristics were comparable. The incidence of postoperative pancreatic fistula in the combination group was 11.7%, significantly lower than that in the control group (23.3%; odds ratio = 0.43, 95%CI: 0.21-0.89, P = 0.022). The combination group also had significantly shorter drain retention days (8.8 ± 3.5 days vs 12.1 ± 4.8 days, P = 0.018) and postoperative hospital stay (14.5 ± 5.3 days vs 19.2 ± 7.1 days, P = 0.026). No significant inter-group differences were found in mean blood glucose, blood glucose coefficient of variation, daily insulin dosage and the incidence of hypoglycemic events (all P > 0.05). CONCLUSION In diabetic patients undergoing PD, the combined regimen was associated with a reduced incidence of postoperative pancreatic fistula, shorter drainage duration, and a shorter hospital stay without significantly affecting postoperative glycemic variability.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →